<DOC>
	<DOC>NCT02594410</DOC>
	<brief_summary>To evaluate the efficacy of renal artery stent combined with standardized medical therapy as treatment for renal artery stenosis.</brief_summary>
	<brief_title>Zainidip in Renal Artery Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Lercanidipine</mesh_term>
	<criteria>Age between 40 75 Diameter of stenosis of renal artery or main branch of renal artery ≥60％. If diameter of stenosis is 60% 75%, pressure difference between proximal and distal end ≥20 mm Hg (1mmHg=0.133kPa) or Captopril renography positive; Systolic blood pressure before taking antihypertensive ≥180mmHg and/or diastolic blood pressure ≥110 mmHg; taking three antihypertensive including one diuretics with systolic blood pressure ≥140mmHg and/or ≥90 mmHg; length of ipsilateral kidney is greater than 7.0cm. Estimated glomerular filtration rate (eGFR) ＜30 ml/ (min﹒1.73 m 2) [eGFR (mL/min/1.73 m2) = 186.3 * serum creatinine (mg/dl) 1.154 * Age0.203 * 0.742 (female)[11]; unstable condition and unable to tolerate interventional therapy; anatomy of renal artery pathology not suitable for interventional therapy; allergic to dihydropyridines; III degree atrioventricular block contrast allergy ; any known malignant tumor; noncompliant, history of alcoholism or drug abuse.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>